DHEA for Longevity: Benefits, Risks and Why We Test DHEA-S First
AI Overview: DHEA is a steroid hormone produced primarily by the adrenal glands. It also serves as a precursor from which the body can make other hormones, including testosterone and estrogen. Its circulating sulfate form, DHEA-S, declines considerably with age, which has helped make DHEA a longstanding part of the anti-aging conversation. The decline is real, but it does not mean that every older adult is deficient or should take DHEA. At HormoneSynergy®, we generally evaluate DHEA-S rather than relying on symptoms or age alone, and we interpret it in the context of the patient's broader hormonal and medical picture.
One-Minute Read
DHEA production rises during adolescence, reaches its highest levels in early adulthood and falls progressively with age. That pattern has made DHEA attractive as an anti-aging supplement, but restoring a hormone that declines with age is not the same thing as reversing aging.
DHEA is biologically active. It can be converted into testosterone, estradiol and other steroid hormones, which means supplementation can have effects well beyond the DHEA-S number on a laboratory report. In women, excessive androgen exposure may show up as acne, increased facial hair or scalp hair changes. DHEA can also influence estrogen exposure in both women and men.
For routine evaluation, HormoneSynergy® generally uses DHEA-S rather than serum DHEA. DHEA-S circulates at much higher concentrations and is considerably more stable, making it more useful for assessing adrenal androgen status and monitoring supplementation.
DHEA may have selected benefits in areas such as bone density, body composition or mood, but the effects in clinical trials have generally been modest and inconsistent. It has not been shown to extend human lifespan, prevent dementia or broadly reverse aging. We therefore prefer to test first, decide whether there is a clinical reason to intervene, and monitor the response rather than treating an age-related laboratory change as a diagnosis.
Editorial Transparency: HormoneSynergy® offers DHEA supplements through RetzlerRx®. We have a financial interest in supplement sales. That does not change our clinical position. We do not believe that age-related decline in DHEA-S alone is a reason to supplement, and we prefer laboratory testing and clinical evaluation before recommending hormone-active products.
DHEA and Aging
DHEA, or dehydroepiandrosterone, is produced primarily by the adrenal cortex. A substantial portion circulates as dehydroepiandrosterone sulfate, or DHEA-S.
DHEA is often described as a hormone precursor because tissues can convert it into androstenedione, testosterone, estrone and estradiol. That is an important distinction from a vitamin, mineral or conventional nutritional supplement. Changing DHEA intake can change other hormone pathways as well.
Both DHEA and DHEA-S rise during adolescence, reach their highest concentrations in early adulthood and then decline over the following decades. The age-related decline is sometimes referred to as adrenopause, although it is quite different from menopause because adrenal production does not abruptly stop.
The decline helped establish one of the earliest theories behind DHEA supplementation for healthy aging: younger people have more DHEA, older people have less, so perhaps restoring it might reproduce some aspect of younger physiology.
That idea has been studied for decades. The results have been considerably more restrained than the marketing that grew around it.
Lower DHEA-S with age is a biologic observation. It is not, by itself, proof of a hormone deficiency, and it does not establish that raising the level will extend life or reverse aging.
Why HormoneSynergy® Tests DHEA-S
When we want to assess adrenal androgen production, DHEA-S is generally more useful than serum DHEA. DHEA itself changes relatively quickly, while DHEA-S circulates at much higher concentrations and is more stable over the course of the day.
For that reason, the laboratory measurement we generally pay attention to is:
DHEA-S — Dehydroepiandrosterone Sulfate
The number still requires interpretation. DHEA-S varies greatly according to age and sex, so a result that might be unusually low in a younger adult may be entirely expected later in life. Laboratory reference ranges reflect some of that difference, but reference ranges do not replace clinical judgment.
We also look at what is happening around the DHEA-S result. Symptoms, menopausal status, medication use, hormone therapy and medical history all matter. Depending on the patient, testosterone, estradiol, sex hormone-binding globulin and other hormone measurements may help put the result in perspective.
A low DHEA-S result does not automatically explain fatigue, prove adrenal disease or establish a need for supplementation. It is one piece of a larger assessment.
This is the same reasoning behind our Optimal Aging Assessment. Testing is most useful when the result changes what we do. A laboratory value has very little value if it simply creates another number to optimize.
Should DHEA-S Be Restored to a Younger Level?
There is no established longevity guideline recommending that a healthy 60-, 70- or 80-year-old raise DHEA-S to the concentration typical of a young adult.
One of the most important randomized trials of DHEA replacement followed older adults with relatively low DHEA-S for two years. Supplementation successfully raised hormone concentrations, but the investigators did not find physiologically important improvements in the broader aging outcomes they examined, including body composition, physical performance, insulin sensitivity and quality of life.
The study is useful because it separates two questions that are often treated as though they were the same. DHEA supplementation can raise DHEA-S. That does not mean raising DHEA-S produces a meaningful anti-aging effect.
The Endocrine Society does recommend DHEA-S monitoring in a much narrower setting: selected women with primary adrenal insufficiency who undergo a therapeutic trial of DHEA. In that population, the guideline suggests measuring morning DHEA-S before the daily dose and using a physiologic range rather than pushing levels upward without limit.
That recommendation applies to adrenal insufficiency. It is not a longevity guideline for otherwise healthy adults. It does, however, illustrate a reasonable principle when DHEA is used clinically: the objective is physiologic hormone support, not the highest number the laboratory will allow.
What the Evidence Shows
Bone Density
Bone health is one of the areas where DHEA has produced a modest but reasonably consistent signal, particularly in older women.
Randomized trials and meta-analyses have reported small improvements in bone mineral density with supplementation. The effect has generally been more apparent in women than men, and changes at individual skeletal sites have often been on the order of approximately one percent.
That is enough to make the finding interesting, but not enough to make DHEA a primary treatment for osteopenia or osteoporosis.
Bone health is better addressed by first knowing what is happening. That may include DEXA bone density testing, assessment of fracture risk, adequate protein and mineral intake, resistance exercise, attention to fall risk and osteoporosis medication when indicated.
DHEA may have a place in selected patients. It should not displace the interventions with much stronger evidence.
Body Composition and Muscle
DHEA has also been studied for its effects on lean mass, fat mass and physical performance. Some meta-analyses have found small changes in body composition, including a modest increase in lean body mass or reduction in fat mass. Improvements in strength and physical performance have been much less consistent.
Studies in older men have also raised an important mechanistic question: some of the body-composition effects attributed to DHEA may be explained by its conversion into testosterone and estrogen rather than by a unique effect of DHEA itself.
For patients concerned about sarcopenia, the larger clinical priorities remain progressive resistance training, adequate protein, recovery and objective monitoring of muscle over time. HormoneSynergy® uses DEXA and SECA body composition analysis when appropriate because they allow us to follow actual changes in lean mass and fat rather than assuming that a supplement is helping.
Mood
DHEA has been studied in depression and mood disorders, with some randomized trials reporting improvement in depressive symptoms. Meta-analyses have found a possible benefit, but the studies are relatively small and heterogeneous, and the quality of the evidence has generally been rated as low or very low.
That leaves DHEA in an interesting but uncertain position. Some patients may notice a subjective change in mood or well-being, but the evidence does not support recommending DHEA broadly as an antidepressant or mood supplement.
Sexual Function
DHEA is frequently marketed for libido, particularly in women. Oral DHEA trials have produced inconsistent results, and raising circulating androgen or estrogen precursors does not reliably translate into improved sexual function.
Prescription vaginal prasterone is different. Vaginal prasterone has an established role in treating certain postmenopausal vulvovaginal symptoms and painful intercourse. That local therapy should not be confused with the evidence for oral DHEA as a general libido or longevity supplement.
Cognitive Function
DHEA and DHEA-S have attracted considerable interest as neuroactive steroids, and observational studies have explored possible relationships between these hormones, cognition and brain aging.
The randomized clinical evidence has been much less encouraging. The DHEA and Well-Ness, or DAWN, trial did not find improvement in cognitive performance or overall well-being in healthy older adults receiving DHEA. Other reviews have reached similar conclusions.
At this point, there is no good evidence for recommending DHEA to prevent Alzheimer's disease or age-related cognitive decline.
Does DHEA Extend Lifespan?
There is no convincing clinical evidence that taking DHEA extends human lifespan.
Observational studies have reported associations between endogenous DHEA-S concentrations and various health outcomes, including mortality. Those studies can be useful, but they cannot tell us whether low DHEA-S contributes to poorer health or simply accompanies aging, chronic illness, frailty, medication use or changes in adrenal function.
The distinction is important. A marker associated with longevity does not automatically become a longevity treatment when it is given as a supplement.
A 2025 analysis examining DHEA-S and lifespan again highlighted the same limitation that has followed this field for years: clinical trials have not shown that DHEA supplementation prolongs human life.
For that reason, we view DHEA as a potentially useful hormone intervention in selected patients rather than as a longevity therapy in its own right.
For a broader discussion of the measurements and interventions that have greater influence on long-term health, see What Actually Moves Longevity Metrics.
DHEA Can Change Testosterone and Estrogen
Anyone considering DHEA should understand that it does not remain isolated within the DHEA pathway.
DHEA can be converted into downstream androgens and estrogens. Supplementation may therefore increase testosterone, estradiol or both, with considerable variation according to age, sex, dose and individual metabolism.
Clinical trials in older women have demonstrated measurable increases in testosterone with DHEA supplementation, and estradiol may rise as well. These effects become particularly relevant at higher supplemental doses.
That is why we do not regard DHEA as a separate issue in someone already receiving testosterone, estrogen or other hormone therapy. Adding another steroid hormone precursor can change the balance of the entire system.
Our broader approach is discussed in Bioidentical Hormone Therapy for Women and Men.
Risks and Reasons for Caution
DHEA has generally been well tolerated in short-term clinical trials at commonly studied doses, but the absence of frequent serious adverse events over months or a few years is not the same as demonstrating long-term safety for decades of unsupervised supplementation.
Women may be especially sensitive to excessive androgen exposure. Acne, oily skin, increased facial or body hair and scalp hair changes can occur when androgen levels rise too far.
DHEA can also alter estrogen exposure. That deserves additional consideration in people with a personal history of hormone-sensitive malignancy or another condition in which changes in estrogen or androgen signaling may matter.
It would be an overstatement to say that DHEA causes breast or prostate cancer. The available evidence does not support such a simple conclusion. It is equally inappropriate to assume that long-term supplementation is risk-free simply because DHEA is available without a prescription.
DHEA may also affect lipids. A meta-analysis of randomized trials found no significant overall effect on total cholesterol, LDL cholesterol or triglycerides, while HDL cholesterol appeared to decrease in some populations.
These are the kinds of details that become lost when DHEA is sold as a generic anti-aging supplement rather than treated as a hormone-active compound.
When an Abnormal DHEA-S Deserves More Evaluation
Low DHEA-S becomes increasingly common with age and may have little clinical significance by itself. Markedly abnormal results, however, deserve context rather than an automatic supplement recommendation.
Low adrenal androgen production may occur in adrenal insufficiency, pituitary disorders and people using glucocorticoid medications. When symptoms or other laboratory findings raise concern for adrenal disease, the appropriate response is to evaluate adrenal function rather than simply adding DHEA.
An unexpectedly high DHEA-S can also be important. Increased adrenal androgen production may occur in conditions such as polycystic ovary syndrome, and substantial elevations occasionally require evaluation for less common adrenal disorders.
In either direction, the DHEA-S value has to make sense alongside the patient's history, symptoms and other laboratory findings.
How We Approach DHEA at HormoneSynergy®
We generally begin with a baseline DHEA-S rather than assuming that fatigue, reduced libido or aging itself reflects a DHEA problem. Depending on the clinical situation, testosterone, estradiol, SHBG and other hormone measurements may also be relevant.
We interpret the result according to age, sex and the rest of the patient's hormonal and medical picture. A laboratory flag does not become a diagnosis simply because it appears outside a reference interval, and a low DHEA-S level by itself does not establish that supplementation will improve health.
When DHEA is used, we prefer physiologic dosing rather than attempting to reproduce the hormone level of a much younger person. This is especially important in women, where excessive androgen exposure can become apparent fairly quickly.
DHEA-S can then be rechecked along with other relevant hormone markers when appropriate. A consistent testing routine is useful when following changes over time. In patients receiving DHEA replacement for adrenal insufficiency, the Endocrine Society recommends measuring morning DHEA-S before the day's dose. Although that recommendation was not written as a longevity protocol, testing before the daily dose is a reasonable way to reduce unnecessary variability when monitoring supplementation.
We also do not assume that a hormone should be continued indefinitely simply because it was started. If there is no meaningful clinical benefit, laboratory values move in an undesirable direction or adverse effects develop, continued use should be reconsidered.
What About DHEA 10 mg, 25 mg or 50 mg?
Many clinical trials have used 50 mg of DHEA daily. That does not make 50 mg the correct dose for an individual patient, and it certainly does not make it a reasonable starting point for everyone interested in longevity.
Women in particular can experience meaningful changes in testosterone and estrogen at doses commonly used in research. Lower-dose options can make more individualized supplementation possible when there is a reason to use DHEA.
HormoneSynergy® carries RetzlerRx® DHEA 10 mg and RetzlerRx® DHEA 25 mg. Their availability should not be read as a recommendation that everyone take DHEA. They are simply options for people in whom DHEA supplementation has been determined to be appropriate.
The more useful question is not whether 10 mg, 25 mg or 50 mg is the best anti-aging dose. It is whether DHEA makes sense for the individual, what the baseline DHEA-S shows, how other hormones may be affected and whether supplementation produces a benefit worth continuing.
Where DHEA Fits in Longevity Medicine
DHEA occupies an unusual place in longevity medicine. Its biology is real, its age-related decline is well established, and supplementation clearly changes hormone levels. There are also selected clinical situations in which DHEA may be useful.
What has never been established is the much larger claim that restoring DHEA-S broadly reverses aging or extends life.
That difference matters.
Our goal at HormoneSynergy® is not to make every laboratory value resemble the result of a 25-year-old. We are interested in whether a measurement identifies something that is impairing health, function or long-term risk and whether changing it is likely to improve the patient's outcome.
DHEA sometimes belongs in that conversation. Sometimes it does not. The laboratory work, the clinical context and the response to treatment should make that decision—not the fact that DHEA declines with age.
Medicine. Not Marketing.
Frequently Asked Questions
What is the best blood test for DHEA?
DHEA-S is generally the more useful routine blood marker because it circulates at much higher concentrations and is more stable than unconjugated DHEA. HormoneSynergy® typically uses DHEA-S when evaluating adrenal androgen status.
Does DHEA-S decline with age?
Yes. DHEA and DHEA-S generally peak in early adulthood and decline substantially with age. That does not mean every older adult is deficient or that supplementation is automatically indicated.
Should DHEA-S be restored to the level of a 25-year-old?
There is no established longevity guideline recommending youthful DHEA-S concentrations for healthy older adults. HormoneSynergy® favors individualized interpretation and physiologic hormone support rather than deliberately maximizing DHEA-S.
Does DHEA extend lifespan?
No human clinical trial has established that DHEA supplementation extends lifespan. Observational associations between endogenous DHEA-S and health outcomes do not prove that supplementation produces the same effect.
Can DHEA increase testosterone?
Yes. DHEA can be converted into downstream androgens, and clinical trials have demonstrated increases in testosterone, particularly in women. It can also influence estradiol.
Can DHEA help bone density?
Some randomized trials and meta-analyses suggest modest improvements in bone mineral density, particularly in older women. DHEA should not replace DEXA testing, resistance exercise, adequate nutrition or established osteoporosis treatment when those are indicated.
Does DHEA prevent dementia?
No. Randomized human trials have not established DHEA as a treatment for preventing Alzheimer's disease or age-related cognitive decline.
Should I test DHEA-S before taking DHEA?
That is generally the HormoneSynergy® approach. A baseline DHEA-S helps place supplementation in context and provides a measurement that can be followed if treatment is started.
Related HormoneSynergy® Resources
- Optimal Aging Assessment
- Bioidentical Hormone Therapy for Women and Men
- DEXA Bone Density, Body Composition & Visceral Fat Testing
- What Actually Moves Longevity Metrics
- HormoneSynergy® Longevity Medicine Resource Library
Selected Medical References
- Nair KS, et al. DHEA in elderly women and DHEA or testosterone in elderly men. New England Journal of Medicine. 2006. PubMed.
- Bornstein SR, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. Endocrine Society.
- Jankowski CM, et al. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults. PubMed.
- Lin H, et al. Systematic review and meta-analysis of randomized controlled trials evaluating DHEA and bone mineral density. PubMed.
- Kritz-Silverstein D, et al. Effects of DHEA supplementation on cognitive function and quality of life: the DAWN Trial. PubMed.
- Wang F, et al. Effects of DHEA supplementation on body composition and blood pressure: meta-analysis of randomized clinical trials. PubMed.
- Qin Y, et al. Effects of DHEA supplementation on the lipid profile: systematic review and meta-analysis of randomized controlled trials. PubMed.
- Peixoto C, et al. Dehydroepiandrosterone for depressive symptoms: systematic review and meta-analysis of randomized controlled trials. PubMed.
- Schooling CM, et al. Dehydroepiandrosterone sulfate and lifespan. 2025. PubMed.
Medical Disclaimer: This article is educational and is not a substitute for individualized medical care. DHEA is a hormonally active substance and may not be appropriate for every person. Hormone testing, supplementation and hormone therapy should be discussed with a qualified healthcare professional familiar with your medical history, medications and laboratory results.
HormoneSynergy® Longevity Medicine
Portland • Lake Oswego • Oregon
Evidence-Based Preventive Longevity Medicine
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.
Return to the Longevity Medicine Guide →